for needle puncture and subcutaneous injectate, (5µl, 0.9%). To assess the development of tissue edema, we recorded the dorsal-ventral thickness of the injured paw with a fine digital caliper.
Plantar incision model of post-operative pain.
Mice were anesthetized with isoflurane anesthesia (1.5-2%) and the surface of the left hindpaw was wiped with antiseptic and alcohol. Using a #11 scalpel blade, an incision was begun 3 mm from the proximal edge of the heel, and extended 7 mm towards the digits (23) . The underlying muscle was incised longitudinally. The skin was closed with two nylon 6-0 sutures and antibiotic ointment was applied. Sham animals underwent the same procedure without incision of the underlying muscle. Sutures were removed on Post-Operative Day 10.
Mouse (in vivo) drug administration
For subcutaneous injections (200 µl), unanaesthetized mice were lightly restrained and injected with a 27 G needle under the skin of the back, above the lumbar region. For intrathecal injections (5 µl), unanaesthetized mice were lightly restrained and a 30 G needle attached to a Hamilton microsyringe was inserted between the L5/L6 vertebrae and then punctured through the dura (confirmation by presence of reflexive tail flick) as previously described (52) . For intraperitoneal injections unanaesthetized mice were lightly restrained and a 27 G needle was inserted through the abdominal wall into the peritoneal space and drugs were administered in a 200 µl volume. For chronic drug infusion, we implanted subcutaneous osmotic mini-pumps (0.25μl/hr for 14 d). Pumps were primed in 37 °C saline for 48 hr prior to surgical implantation according to the manufacturer's instructions. Under isoflurane anesthesia (5% induction followed by 1.5-2.0% maintenance), a subcutaneous pocket was created above the lumbar region of the spinal column with a 1 cm skin incision above the scapulae, followed by blunt dissection of the skin from the connective tissues with blunt tipped scissors. The pump was then inserted with the flow moderator facing caudally, which rested just above the lumbar region of the spinal column. The skin incision was then sutured closed and wiped with Betadine. The pump was removed after 14d under anesthesia, followed by sterile wound closure and wiped with Betadine.
Drug dosing
The following drugs and doses were used for in vivo experiments: naltrexone HCl (NTX, 
Mechanical hyperalgesia testing
All testing was begun between 10:00 am and noon in a temperature-and light-controlled room. Mice were acclimated for 30 -60 min in the testing environment within a rectangular plastic box (15x4x4 cm; 3 white opaque walls and 1 clear wall) on a raised metal mesh platform. Baseline testing was conducted prior to and after injury, and at various time points after drug injection (as indicated in the figures). To evaluate mechanical hypersensitivity (hyperalgesia) we used a logarithmically increasing set of 8
von Frey filaments (Stoelting, Illinois), ranging in gram force from 0.007 to 6.0 g. These were applied perpendicular to the ventral-medial hindpaw surface with sufficient force to cause a slight bending of the filament. A positive response was characterized as a rapid withdrawal of the paw away from the stimulus fiber within 4 s. Using the up-down statistical method (53), the 50% withdrawal mechanical threshold scores were calculated for each mouse and then averaged across the experimental groups.
Conditioned Place Preference
The CPP apparatus consists of 3 Plexiglas chambers separated by manual doors. A center (54) . The images were randomized and scored for facial grimacing using the Mouse Grimace Scale as previously described previously (55) .
pERK stimulation studies A light-touch stimulation protocol was used as previously described (56) . Briefly, mice were injected with vehicle or drug, and then 30 min later were anesthetized with isoflurane (1.5 %). A cotton-tip was gently stroked across the plantar surface of the ipsilateral hindpaw, once every 5 s for 5 min. After an additional 5 min, mice were transcardially perfused with 10% buffered formalin and the lumbar spinal cord was dissected. Control mice that did not receive the light-touch stimulation still underwent isoflurane anesthesia.
Histology and Immunohistochemistry
Mice were deeply anesthetized with isoflurane or an intraperitoneal overdose injection of Fatal Plus (86 mg/kg). Mice were then perfused with ice-cold PBS/heparin followed by ice-cold 10% buffered formalin. Spinal cords (L3 -L5) were postfixed in 10% formalin, cryoprotected in 30% sucrose, and sectioned at 30 μm on a sliding microtome. cAMP ELISA assay
For in vivo detection of intracellular cAMP levels, lumbar spinal cords were rapidly dissected 30 min after intrathecal injection. L3-L5 segments were quickly blocked, frozen on dry ice, and stored at -80 ºC for later use. cAMP measurements were performed using a direct cAMP enzyme immunoassay according to the manufacturer's protocol (nonacetylated protocol with sensitivity = 0.39 pmol/ml; Enzo Life).
We utilized entire lumbar spinal cord section (dorsal and ventral) for the following reasons: 1) it was necessary to use the dorsal and ventral aspects to achieve sufficient sample (protein) quantities to run the cAMP ELISA in duplicate as well as to run a concurrent Bradford protein assay in duplicate for each spinal cord sample; 2) only dorsal horn neurons exhibited increased pERK expression, suggesting that the latent central sensitization processes exist in this region; and 3) The large majority of MOR expression is in the dorsal horn as well (57) . Therefore, we believe that changes in cAMP reflect events in the dorsal horn and not the ventral horn.
GTPγS 35 binding assay
The lumbar enlargement of the spinal cord was removed by hydrostatic pressure ejection and snap-frozen in methyl butane. 25 μm thick sections were cut and mounted on positively charged glass slides. All sections were treated identically. Therefore, any residual opioid content (as well as other conditions) was identical between the sections used for basal determinations or those incubated with or without β-funaltrexamine.
Incubation in buffer for a total of 25 min is sufficient to wash out any opioid peptides or other agonists in the extracellular space before incubation with GTPγS 35 . Sections were equilibrated in assay buffer (3 mM MgCl2, 100 mM NaCl, 0.2 mm EDTA, and 50mM
Tris, pH 7.4) for 10 min and then in 1 mM (β-FNA studies) or 2 mM (DAMGO studies)
GDP for 15 min both at room temperature. Agonist-stimulated binding was then ]i in CFA-21d spinal cord slices (n = 4 mice, total of 6 slices) and sham slices (n = 2 mice, total of 4 slices) in contralateral lamina I-II cells.
Fig. S8. NMDA-R signaling is necessary for contralateral pERK immunoreactivity during opioid receptor blockade.
Effect of intrathecal MK-801 (1µg) on NTX-induced (1µg) pERK expression in lamina I-II (left) or III-V (right), contralateral to light-touch stimulation of the left hindpaw (n = 6-10).  P < 0.05. Student's t test. All data shown as mean ± s.e.m. 3) (F3,10 = 9.9, P < 0.005) on mechanical thresholds 105d after CFA. Prior to experimentation, mice only received CFA, and were never exposed to drugs, behavioral testing equipment, or the testing room. 
Supplementary Notes
Supplementary Text S1
The induction phase of CFA-hyperalgesia (<24 hrs after injury) is dependent on spinal NMDA-R signaling, whereas the maintenance phase of hyperalgesia has NMDA-Rindependent components. As illustrated in fig. S1A -C, NTX does not increase hyperalgesia or glutamate-evoked spinal [Ca 2+ ]i 24 hr after CFA, suggesting that the endogenous opioidergic system does not impinge on the induction of CFA-hyperalgesia. In contrast, as illustrated in Figure 1B , continuous infusion of NTX over the first 14d after CFA eliminated endogenous opioid analgesia, suggesting that the opioidergic system opposes the maintenance of CFA-hyperalgesia. Taken together, our data suggest that the cellular mechanisms of the induction and maintenance of latent hyperalgesia in our model are different.
Supplementary Text S2
Basal spinal cAMP levels were similar between shams and CFA-21d animals with MORCA. This could reflect a two-stage homeostatic process similar to that which occurs following chronic opiate administration. First, CFA might initiate an endogenous MORmediated decrease in cAMP. Second, a homeostatic up-regulation of AC would normalize cAMP levels back to baseline levels. Indeed, as occurs after chronic opioid administration, we demonstrated not only increased sensitivity to intrathecal forskolin, but also cAMP overshoot after administration of opioid receptor inverse agonists.
Supplementary Text S3
It remains an interesting question as to what mechanisms initiate and maintain constitutive signaling after inflammation. Chronic stimulation of MORs with repeated morphine administration can produce constitutive activity; this is enhanced by endogenously released enkephalins (20) . Therefore, we believe that injury increases spinal opioid peptide release, which then facilitates the induction of MORCA. While we have no direct evidence of the molecular mechanisms driving the acquisition of MORCA in our model, we refer to the Extended Ternary Complex model of GPCR signaling (32) . In this modeling paradigm, constitutive activity can be produced by lowering the energy barrier to generate the spontaneous formation of the receptor active state. This is referred to as a decrease in allosteric constant, and might be achieved through post-translation modification of MOR (e.g. hyper-phosphorylation) (17) or a reduction in the association of the receptor with a negative regulatory protein, such as β-arrestin2 (37) .
Supplementary Text S4
A large body of evidence indicates that naltrexone can act as an inverse agonist while 6β-naltrexol is a neutral antagonist, particularly in the setting of chronic opiate exposure (35, 37, 62) .
Supplementary Text S5
Repeated administration of opiates typically produce tolerance in rodents. We found that tonic MOR signaling lasted for months after CFA, without signs of endogenous tolerance (i.e. return of hyperalgesia). This might be explained by a bias of endogenous opioids that favors analgesia over analgesic tolerance mechanisms, such as β-arrestin2-mediated receptor internalization (63) . Several pieces of evidence support this. First, CFA reduces morphine cross-tolerance (64) . Second, β-arrestin2 KO mice exhibit increased morphine antinociception (63) and decreased tolerance (65) that rely on MOR constitutive activity (37) . Third, the enkephalinase inhibitor, RB101, produces analgesia that does not undergo tolerance or cross-tolerance to morphine (66) .
Supplementary Text S6
Naloxone can produce hyperalgesia in humans, indicating the presence of endogenous opioid analgesia (67) (68) (69) . Furthermore, tonic pain causes the release of endogenous substances acting at MORs in the brain (70) , and induces long-lasting activation of spinal MOR (71) . Our data suggest that endogenous activation of MORs will initiate both analgesic signaling as well as a standard compensatory opponent-processes that can lead to a rebound effect when an inverse agonist is given (i.e. withdrawal symptoms). Indeed, anecdotal evidence supports the idea that endogenous opioidergic mechanisms lead to physical dependence in humans. For example, naltrexone can induce withdrawal-like symptoms including nausea and jitteriness (72) .
Supplementary Text S7
Unilateral injuries often produce bilateral hyperalgesia, and the current data extends this to latent pain sensitization in CFA 21-day mice. NTX produced bilateral hyperalgesia and bilaterally increased stimulus-evoked pERK expression. Leading explanations for bilateral hyperalgesia include descending facilitatory fibers from the brainstem (73, 74) and reactive spinal astrocytes communicating through gap-junction networks (56, 75) . We found evidence for bilateral expression of MORCA, namely contralateral increases in DAMGO-induced MOR-G-protein coupling and β-funaltrexamine-induced decreases in basal MOR-G-protein coupling. We suggest that MORCA is intricately involved in the regulation of contralateral sensitization, and thus chronic pain phenotypes that display widespread hypersensitivity, such as fibromyalgia.
Supplementary Text S8
NTX-induced pain reinstatement (e.g. abrupt withdrawal from MORCA by an inverse agonist) could result from either: 1) disinhibition of tonically active primary afferent terminals: 2) disinhibition of AC1 superactivation in dorsal horn neurons; 3) potentiation of descending facilitatory signals from the brainstem; and/or 4) induction of de novo spinal NMDA-R-dependent withdrawal. While we have no direct evidence of withdrawal-induced de novo LTP, several of our data and other studies suggest this as a promising area of future investigation: 1) Exogenous opiate withdrawal in the spinal cord initiates de novo NMDA-R-dependent LTP (12, 76) ; 2) NMDA-R signaling and post-synaptic spinal neuron Ca 2+ rise are required in the induction, rather than maintenance, of spinal LTP and hyperalgesia (77, 78) ; 3) AC1 is activated by NMDA-R-derived Ca 2+ and is necessary for LTP induction (30, 79, 80) ; 4) Intrathecal NMDA (3 pmol) increased pain behaviors and spinal cAMP levels in CFA-21d mice compared to shams (Fig. 2H and 2I ). This suggests that spinal NMDA-R-adenylyl cyclase signaling pathways are not occluded (saturated); and 5) Intrathecal MK-801alone did not increase mechanical threshold (Fig. 2D) , decrease basal pERK expression (Fig. 2E) , or decrease basal cAMP levels (Fig. 2G) when administered during the post-hyperalgesia state. And MK-801 perfusion did not reduce basal spinal intracellular calcium levels from CFA-21d slices (Fig 2C) . These findings suggest that spinal NMDA-Rs are not active prior to NTX-induced withdrawal.
